The Institute for Orphan and Rare Diseases (IFORD) was created in 2023 as a branch of the Eval Research Institute EVALRI, an independent research organization born in the heart of Silicon Valley with over 30 years of experience refining Artificial Intelligence technology and deploying customized medical and industry applications.
The mission of IFORD is to contribute to the study of orphan and rare diseases by using artificial intelligence tools and expertise to address specific challenges associated with very small numbers of individuals with specific diseases in the general population.
IFORD combines expertise across medical, scientific, pharmaceutical industry, and technology domains to develop evidence-based data solutions across multiple rare diseases and to develop and deploy customized artificial intelligence assessment tools.
Study the prevalence and incidence of rare diseases in the general population.
Foster innovative research for the screening and early detection of rare disease.
Contribute to the development of treatments.
Generate insights for public health and regulatory considerations.